Federal Register of Legislation
Statement of Principles concerning HEPATITIS B (Reasonable Hypothesis) (No. 13 of 2017) The Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(2) of the Veterans' Entitlements Act 1986.
Dated 20 December 2016
The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
Professor Nicholas Saunders AO Chairperson
Contents 1 Name 2 Commencement 3 Authority 4 Revocation 5 Application 6 Definitions 7 Kind of injury, disease or death to which this Statement of Principles relates 8 Basis for determining the factors 9 Factors that must exist 10 Relationship to service 11 Factors referring to an injury or disease covered by another Statement of Principles Schedule 1 - Dictionary 1 Definitions
1 Name This is the Statement of Principles concerning hepatitis B (Reasonable Hypothesis) (No. 13 of 2017). 2 Commencement This instrument commences on 23 January 2017. 3 Authority This instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986. 4 Revocation The Statement of Principles concerning hepatitis B No. 52 of 2008 made under subsection 196B(2) of the VEA is revoked. 5 Application This instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies. 6 Definitions The terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument. 7 Kind of injury, disease or death to which this Statement of Principles relates (1) This Statement of Principles is about hepatitis B and death from hepatitis B. Meaning of hepatitis B (2) For the purposes of this Statement of Principles, hepatitis B means infection with the hepatitis B virus resulting in: (a) an acute, symptomatic, clinical illness characterised by inflammation of the liver and commonly accompanied by fever, tiredness, loss of appetite, nausea, vomiting, abdominal discomfort and jaundice; or (b) a chronic infection of at least six months duration and which may involve both inflammation of the liver and the development of fibrosis in the longer term. Both acute and chronic infection must be confirmed by laboratory testing for hepatitis B serological or nucleic acid markers, or both. (3) While hepatitis B attracts ICD‑10‑AM code B16, B18.0 or B18.1, in applying this Statement of Principles the meaning of hepatitis B is that given in subsection (2). (4) For subsection (3), a reference to an ICD‑10‑AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD‑10‑AM), Ninth Edition, effective date of 1 July 2015, copyrighted by the Independent Hospital Pricing Authority, ISBN 978‑1‑76007‑020‑5. Death from hepatitis B (5) For the purposes of this Statement of Principles, hepatitis B, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's hepatitis B. Note: terminal event is defined in the Schedule 1 – Dictionary. 8 Basis for determining the factors The Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that hepatitis B and death from hepatitis B can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA. Note: relevant service is defined in the Schedule 1 – Dictionary. 9 Factors that must exist At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting hepatitis B or death from hepatitis B with the circumstances of a person's relevant service: (1) being exposed to the hepatitis B virus at least 30 days before the clinical onset of hepatitis B; Note: being exposed to the hepatitis B virus is defined in the Schedule 1 - Dictionary. (2) living or working for a continuous period of at least 90 days in an area which, at that time, has a population prevalence of hepatitis B chronic infection of at least 2% before the clinical onset of hepatitis B; (3) for chronic infection only, (a) having been a Prisoner of War of Japan before the clinical onset of hepatitis B; (b) having served in South-East Asia, the Mediterranean region or the Pacific region during World War 2 before the clinical onset of hepatitis B; (c) being treated with an immunosuppressive drug in the five years before the clinical worsening of hepatitis B; Note: being treated with an immunosuppressive drug is defined in the Schedule 1 - Dictionary. (d) being infected with human immunodeficiency virus before the clinical worsening of hepatitis B; (e) undergoing solid organ, stem cell or bone marrow transplantation before the clinical worsening of hepatitis B; (f) undergoing a course of therapeutic radiation for cancer, where the liver was in the field of radiation, before the clinical worsening of hepatitis B; (g) for females only, consuming a total of at least 55 kilograms of alcohol within the ten years before the clinical worsening of hepatitis B; Note: alcohol is defined in the Schedule 1 - Dictionary. (h) for males only, consuming a total of at least 110 kilograms of alcohol within the ten years before the clinical worsening of hepatitis B; Note: alcohol is defined in the Schedule 1 - Dictionary. (i) having diabetes mellitus for at least the five years before the clinical worsening of hepatitis B; (j) being obese for at least the five years before the clinical worsening of hepatitis B; Note: being obese is defined in the Schedule 1 - Dictionary. (k) undergoing surgical resection of hepatocellular carcinoma in the two years before the clinical worsening of hepatitis B; (l) being within the six month postpartum period at the time of the clinical worsening of hepatitis B; (m) having severe hepatic iron overload at the time of the clinical worsening of hepatitis B; or Note: iron overload is defined in the Schedule 1 - Dictionary. (n) having evidence of chronic infection with schistosomiasis involving the liver before the clinical worsening of hepatitis B; (4) being infected with the hepatitis A, hepatitis C, hepatitis D or hepatitis E virus before the clinical worsening of hepatitis B; (5) inability to obtain appropriate clinical management for hepatitis B. 10 Relationship to service (1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person. (2) The factors set out in subsections 9(3)(c) to 9(5) apply only to material contribution to, or aggravation of, hepatitis B where the person's hepatitis B was suffered or contracted before or during (but did not arise out of) the person's relevant service. 11 Factors referring to an injury or disease covered by another Statement of Principles In this Statement of Principles: (1) if a factor referred to in section 9 applies in relation to a person; and (2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA; then the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate